Contact Us

Life Sciences

mcubeV3

Enabling Consistency at Scale: The Role of AI in Biologics Manufacturing

From AI Pilots to Production Impact in GxP Environments
  • 24th June | 12:00-12:45 PM EDT
Register Now

Bridging AI experimentation and real manufacturing outcomes by enabling production-ready, compliant systems that improve batch
consistency and decision-making.

About the Webinar

Biologics manufacturing operates in a high-variability, highly regulated environment where small shifts can impact yield, quality, and timelines. While AI investments are widespread, consistent production impact remains limited. This session explores what it takes to move beyond pilots—making AI reliable, traceable, and actionable in real manufacturing environments—supported by a live example from a GxP-regulated workflow.

Core Challenges

  • AI not translating into consistent production outcomes
  • Fragmented process, batch, and material context
  • Insights not embedded into operational decisions
  • GxP constraints limiting deployment
  • High sensitivity to process variability

Key Takeaways

  • Move beyond pilots : Understand what enables real production impact
  • Make insights actionable: Translate outputs into decisions—not dashboards
  • Build GxP-ready AI : Ensure traceability, validation, and auditability
  • Improve consistency : Reduce variability-driven disruptions at scale

Demo 1:  AI-Assisted Regulatory Review

  • AI-powered review of SOPs, deviations, and quality records against FDA & ICH frameworks
  • Citation-backed findings, remediation guidance, and AI-assisted audit response drafting
  • Deterministic, human-reviewed workflows with QMS integration and risk assessment support

Demo 2:  Agentic AI for Intelligent Batch Yield Optimization

  • AI agents to monitor critical process parameters in real time to predict batch yield and quality outcomes
  • Early identification of process variability risks with AI recommendations for optimal operating conditions
  • Improve yield, process robustness, and scale-up consistency through AI-driven manufacturing insights

Our Speakers

Soumyopriyo Saha

Senior Director,
Lifesciences

Panchali Roychoudhury

Senior Director Consulting,
Lifesciences

Angela Bauch

Director Product Management,
TCG Digital

Register Now
Introducing SemantX on mcube™
The Semantic Intelligence Engine for Enterprise AI

SemantX on mcube™ is an enterprise AI solution that tackles the problem of fragmented, hard-to-discover data by creating a unified, context-rich knowledge layer powered by semantics, ontologies, and knowledge graphs. It connects and contextualizes scientific and operational data across systems, enabling more accurate insights, faster research, and improved decision-making. By combining semantic intelligence with generative AI, it allows users to interact with complex data through natural language, uncover hidden relationships, and accelerate innovation in life sciences while maintaining strong data governance and security.

Download Brochure
explore
Scaling AI in Life Sciences Manufacturing
Download Whitepaper

Overview

Life sciences manufacturing is entering a new era: AI has the potential to reduce batch failures, streamline tech transfers, and unlock millions in operational value. Yet most organizations struggle to move from experimentation to enterprise impact. By adopting a modular AI architecture with intelligent agents and a unified data foundation, manufacturers can accelerate workflows, improve predictive operations, and extract actionable insights from complex manufacturing environments turning scattered processes and raw data into coordinated, decision-ready intelligence.

Key Insight

The central barrier to scaling AI is that production data is siloed, fragmented, and lacks semantic context. MES, LIMS, ERP, and OT systems generate raw signals that cannot be interpreted or linked across processes, batches, and equipment. Without a semantic, ontology-driven layer, AI models cannot generalize beyond pilot projects. Addressing this single bottleneck enables enterprise wide deployment, allowing AI to automate workflows, improve yield, reduce operational risk, and deliver measurable operational and financial outcomes.

Semantic Lakehouse Data Foundation

Modular Non-Disruptive Integration

Continuous Intelligent Validation

Agentic AI for Operations

Enterprise Chat-with-Data

Ontology & Knowledge Graph Intelligence

Download Whitepaper
explore
Accelerating Pharmaceutical R&D Overcoming Challenges through Integrated AI-Driven Platforms
From Molecule to Medicine
Download Whitepaper

Overview

Pharmaceutical R&D faces rising cost, siloed data, and manual workflows slow the journey from molecule to market. This whitepaper introduces a Molecule-to-Medicine acceleration model that uses AI, integrated data platforms, and end-to-end workflows to help organizations drive faster insight-driven decisions and bring therapies to patients sooner.

Key Insight

  • Moving from siloed R&D to an integrated Molecule-to-Medicine model
  • Using AI, knowledge graphs, and generative analytics to speed candidate selection and early manufacturing
  • Scaling AI across discovery, development, and manufacturing while staying compliant
  • A blueprint to compress development timelines by up to six months
  • Integrating knowledge sharing to improve quality and reduce rework

Molecule-to-Medicine acceleration

Faster target identification and candidate selection

Parallelized process development, formulation, and clinical supply manufacturing

Real-time insights across discovery, CMC, and clinical teams

Earlier Go/No-Go decisions to reduce risk

Unified data governance for regulatory readiness and traceability

Download Whitepaper
explore

AI enabled Molecule to
Market Acceleration

The Infrastructure for Intelligence for the
future of the Lifesciences

Download Whitepaper

Overview

mcube™ delivers an AI-powered Infrastructure for Intelligence that transforms how life sciences organizations move from molecule to Phase I. By digitally integrating discovery, development, CMC, and manufacturing into a coordinated execution model, it replaces fragmented handoffs with synchronized, data-driven progression. The measurable result: Phase I readiness accelerated from 18 months to 12 months compressing timelines by up to six months while improving IND readiness, regulatory confidence, traceability, and operational control.

Key Insight

Acceleration occurs because decisions are no longer siloed or sequential. mcube™ establishes a unified, ontology-driven data foundation powered by GenAI, knowledge graphs, predictive modeling, and in-silico simulation. Scientific data, process parameters, and manufacturing insights become contextually connected in real time that enables AI-assisted scientific search, early CPP identification, faster Go/No-Go decisions, reduced experimentation, and first-time-right outcomes. Integrated intelligence across the lifecycle converts complexity into coordinated speed.

Unified Ontology-Driven Data Foundation

GenAI-Enabled Scientific Intelligence

Predictive & In-Silico Modeling

Early CMC & CPP Intelligence

Integrated Workflows

Proven, Real-World Validation

Download Whitepaper
explore
Knowledge Graphs used to Transform & get Siloed Data AI Ready

Knowledge Graphs, Semantic Integration, and AI-Driven Master Data

Download Whitepaper

Overview

This whitepaper explores how mcube™ unifies regulatory and clinical data into a connected, AI-ready knowledge graph, providing a single source of truth. It details how a unified semantic fabric enables faster timelines, smarter outcomes, and traceable insights across R&D.

Key Insight

  • Data silos unified with a FAIR-compliant semantic fabric
  • Automate extraction and master data generation
  • Enabling faster, insight-led regulatory and clinical decisions
  • Reduce manual effort, improve compliance, and accelerate innovation

Connected intelligence across all domains

Automated regulatory & clinical data harmonization

Real-time access to cross-study insights

Audit-ready traceability, compliance and governance

AI-powered analytics and natural language query

Unified master data reducing rework

Download Whitepaper

In today’s rapidly evolving bio-pharma industry, delivering high-quality drugs efficiently while maintaining compliance is a critical challenge. From managing variability in manufacturing processes, to addressing data silos that increase operational costs, these issues demand innovative solutions.

We are addressing these hurdles with mcube™ by TCG Digital, an advanced Data & AI platform designed to optimize operations, break down silos, and drive higher margins.

Download Brochure

Whitepaper

The mcube™ Semantic Lakehouse with Integrated Ontology Layer

Redefining Enterprise Intelligence through Meaning-Driven Data Architecture

October 2025
Download Whitepaper

Whitepaper Overview

Modern enterprises are realizing that the true competitive edge lies not in storing more data—but in understanding it. This whitepaper introduces TCG Digital’s mcube™ Semantic Lakehouse, a next-generation architecture that embeds an ontology layer directly into the data fabric, transforming fragmented data into connected, machine-interpretable knowledge.

By uniting semantic technologies, knowledge graphs, and Generative AI, the mcube™ Semantic Lakehouse enables faster project delivery, trustworthy analytics, and AI systems grounded in real-world context. Readers will discover how this approach helps organizations achieve FAIR data principles (Findable, Accessible, Interoperable, Reusable) from day one—without bolt-on catalogues or costly data cleansing cycles.

The whitepaper explores

The shift from siloed data to actionable knowledge

How ontology-driven design accelerates data harmonization and AI accuracy

Cross-industry use cases across aviation, life sciences, manufacturing, retail, and more

A practical implementation roadmap delivering measurable ROI within 12 months

Discover how enterprises are turning semantics into a force multiplier for AI-driven innovation, regulatory compliance, and digital transformation—powered by the mcube™ platform.

Download Whitepaper

Impact Stories:

How a Composite Biopharma Enterprise Saved $37M Annually

Economic Impact of Agentic AI and Advanced Intelligence in Biopharma Manufacturing powered by mcube™

Download Report

Fill the form to Download Report

A global biologics manufacturer achieved $37M in annual savings by reducing batch failures, optimizing production yields, and improving compliance—powered by mcube™, the AI and advanced analytics platform purpose-built for biopharma.

Based on actual customer deployments, this study explores how mcube™ enables scalable, compliant, and data-driven transformation across R&D, manufacturing, and quality operations.

Why Enterprises Choose mcube™

Built for life sciences and biologics manufacturing

Seamless integration across LIMS, MES, ERP, and QC systems

cGXP-compliant, secure, and scalable

Prebuilt agentic AI applications delivering rapid impact

Report Highlights

Gain a comprehensive view of how mcube™ delivered measurable ROI: AI driven savings.

Showcases alignment of mcube™ with Business Outcomes: accelerating time-to-market to enhancing profitability and operational resilience.

Digital Transformation at Scale: mcube™ enables enterprise-wide adoption of AI without disrupting critical operations.

Slash multi-million-dollar batch failures by improving batch reliability and reducing costly errors.

Boost production yield by maximizing output from limited raw materials without increasing procurement costs.

Cut compliance risks by avoiding expensive fines and ensuring seamless regulatory adherence.

Streamline operations and cut manual hours, enhancing workforce productivity and accelerating time-to-market.

Cost Saving at
Each Stage

Total Economic Impact of mcube™ on the composite enterprise ~ $37 Million

This report provides a structured framework for evaluating financial and operational impact in biopharma with mcube™

Transforming Bioanalytics with AI solutions for a Global Biotechnology Leader. – Powered by mcube™

Reduced
rework cost

Decreased
errors

Enhanced
compliance 

Overview

A leading international biotechnology company sought to streamline its operations and accelerate the delivery of new therapies by digitizing and integrating workflows. The company’s bioanalytics processes, which are critical to its drug development lifecycle, previously consisted of manual workflows involving data transfers between systems. For which, company required AI integration to enhance efficiency, improve accuracy, and accelerate validation. This positioned the company to bring therapies to market more swiftly, reinforcing its commitment to innovation and excellence in drug development.

mcube™ Solutions

Direct analysis from your LIMS,  eliminates risk of data manipulation

Modular design with API connectors to various systems ensures flexibility and scalability

Unified platform for assay analytics across ADA, PK, Method Validation and ICH M10 compliant reporting

Solution that provides ICH M10 and CFR part 11 adherence  

View complete case study